WT1 and myelodysplastic syndrome: Pre-transplant measurable residual disease status of WT1 ccf-mRNA expression has been assessed for prognostic value in peripheral blood obtained from patients with Acute Myeloid Leukemia and Myelodysplastic syndrome (MDS) (Rautenberg et al., 2021).